Effects of Bronchodilatation With Salmeterol on the Autonomic Nervous System

Trial Profile

Effects of Bronchodilatation With Salmeterol on the Autonomic Nervous System

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Apr 2014

At a glance

  • Drugs Salmeterol (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Pharmacodynamics
  • Acronyms ESAN
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 03 Feb 2014 Actual patient number changed from 34 to 32 as reported by ClinicalTrials.gov record.
    • 01 Nov 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top